View Future GrowthSrigee DLM 過去の業績過去 基準チェック /36Srigee DLMは、平均年間27.7%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 成長しています。収益は、平均年間6.3% 10.8%収益成長率で 減少しています。 Srigee DLMの自己資本利益率は11.1%であり、純利益率は7.2%です。主要情報27.72%収益成長率24.76%EPS成長率Chemicals 業界の成長17.68%収益成長率-10.84%株主資本利益率11.11%ネット・マージン7.21%次回の業績アップデート30 May 2026最近の業績更新お知らせ • May 15Srigee DLM Limited to Report Second Half, 2026 Results on May 27, 2026Srigee DLM Limited announced that they will report second half, 2026 results on May 27, 2026Reported Earnings • Nov 16First half 2026 earnings released: EPS: ₹2.25 (vs ₹5.61 in 1H 2025)First half 2026 results: EPS: ₹2.25 (down from ₹5.61 in 1H 2025). Revenue: ₹214.2m (down 39% from 1H 2025). Net income: ₹13.4m (down 44% from 1H 2025). Profit margin: 6.3% (down from 6.8% in 1H 2025). The decrease in margin was driven by lower revenue.お知らせ • Oct 31Srigee DLM Limited to Report Q2, 2026 Results on Nov 12, 2025Srigee DLM Limited announced that they will report Q2, 2026 results on Nov 12, 2025Reported Earnings • Sep 10Full year 2025 earnings released: EPS: ₹11.76 (vs ₹7.09 in FY 2024)Full year 2025 results: EPS: ₹11.76 (up from ₹7.09 in FY 2024). Revenue: ₹712.3m (up 31% from FY 2024). Net income: ₹50.1m (up 72% from FY 2024). Profit margin: 7.0% (up from 5.4% in FY 2024). The increase in margin was driven by higher revenue.Reported Earnings • Jun 03Full year 2025 earnings released: EPS: ₹11.76 (vs ₹7.53 in FY 2024)Full year 2025 results: EPS: ₹11.76 (up from ₹7.53 in FY 2024). Revenue: ₹713.7m (up 31% from FY 2024). Net income: ₹50.1m (up 62% from FY 2024). Profit margin: 7.0% (up from 5.7% in FY 2024). The increase in margin was driven by higher revenue.お知らせ • May 26Srigee DLM Limited to Report Second Half, 2025 Results on May 31, 2025Srigee DLM Limited announced that they will report second half, 2025 results on May 31, 2025すべての更新を表示Recent updatesお知らせ • May 15Srigee DLM Limited to Report Second Half, 2026 Results on May 27, 2026Srigee DLM Limited announced that they will report second half, 2026 results on May 27, 2026Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹64.00, the stock trades at a trailing P/E ratio of 9.5x. Average trailing P/E is 20x in the Chemicals industry in India.New Risk • Nov 27New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$10m (₹710.6m market cap, or US$7.95m).Valuation Update With 7 Day Price Move • Nov 21Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹87.45, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 25x in the Chemicals industry in India.Reported Earnings • Nov 16First half 2026 earnings released: EPS: ₹2.25 (vs ₹5.61 in 1H 2025)First half 2026 results: EPS: ₹2.25 (down from ₹5.61 in 1H 2025). Revenue: ₹214.2m (down 39% from 1H 2025). Net income: ₹13.4m (down 44% from 1H 2025). Profit margin: 6.3% (down from 6.8% in 1H 2025). The decrease in margin was driven by lower revenue.お知らせ • Oct 31Srigee DLM Limited to Report Q2, 2026 Results on Nov 12, 2025Srigee DLM Limited announced that they will report Q2, 2026 results on Nov 12, 2025お知らせ • Sep 30Srigee Dlm Limited Appoints Indu Shekhar Tripathi as Non-Executive Independent DirectorSrigee DLM Limited in the 20th annual general meeting held on September 30, 2025 announced the appointment of Mr. Indu Shekhar Tripathi (DIN: 00654167) as y of the company.New Risk • Sep 26New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹861.1m (US$9.71m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.2% average weekly change). High level of non-cash earnings (38% accrual ratio). Market cap is less than US$10m (₹861.1m market cap, or US$9.71m).Reported Earnings • Sep 10Full year 2025 earnings released: EPS: ₹11.76 (vs ₹7.09 in FY 2024)Full year 2025 results: EPS: ₹11.76 (up from ₹7.09 in FY 2024). Revenue: ₹712.3m (up 31% from FY 2024). Net income: ₹50.1m (up 72% from FY 2024). Profit margin: 7.0% (up from 5.4% in FY 2024). The increase in margin was driven by higher revenue.お知らせ • Sep 08Srigee DLM Limited, Annual General Meeting, Sep 30, 2025Srigee DLM Limited, Annual General Meeting, Sep 30, 2025, at 10:00 Indian Standard Time. Location: plot 39 and 40 udyog vihar, extension, ecotech ii, greater, noida, uttar pradesh, india, 201306, greater noida IndiaValuation Update With 7 Day Price Move • Sep 08Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹170, the stock trades at a trailing P/E ratio of 20.3x. Average trailing P/E is 26x in the Chemicals industry in India.Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹317, the stock trades at a trailing P/E ratio of 37.8x. Average trailing P/E is 29x in the Chemicals industry in India.Valuation Update With 7 Day Price Move • Jun 09Investor sentiment improves as stock rises 33%After last week's 33% share price gain to ₹319, the stock trades at a trailing P/E ratio of 38.1x. Average trailing P/E is 28x in the Chemicals industry in India.New Risk • Jun 03New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 36% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (36% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.44b market cap, or US$16.8m).Reported Earnings • Jun 03Full year 2025 earnings released: EPS: ₹11.76 (vs ₹7.53 in FY 2024)Full year 2025 results: EPS: ₹11.76 (up from ₹7.53 in FY 2024). Revenue: ₹713.7m (up 31% from FY 2024). Net income: ₹50.1m (up 62% from FY 2024). Profit margin: 7.0% (up from 5.7% in FY 2024). The increase in margin was driven by higher revenue.お知らせ • May 26Srigee DLM Limited to Report Second Half, 2025 Results on May 31, 2025Srigee DLM Limited announced that they will report second half, 2025 results on May 31, 2025Board Change • May 12Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Indu Tripathi was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.収支内訳Srigee DLM の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史BSE:544399 収益、費用、利益 ( )INR Millions日付収益収益G+A経費研究開発費30 Sep 255604030030 Jun 256364526031 Mar 257125022031 Mar 245442918031 Mar 234712822031 Mar 223301126031 Mar 212841120031 Mar 2026710110質の高い収益: 544399は 高品質の収益 を持っています。利益率の向上: 544399の現在の純利益率 (7.2%)は、昨年(6.3%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 544399の収益は過去 5 年間で年間27.7%増加しました。成長の加速: 544399の過去 1 年間の収益成長率 ( 1.9% ) は、5 年間の平均 ( 年間27.7%を下回っています。収益対業界: 544399の過去 1 年間の収益成長率 ( 1.9% ) Chemicals業界11.4%を上回りませんでした。株主資本利益率高いROE: 544399の 自己資本利益率 ( 11.1% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/29 11:30終値2026/05/29 00:00収益2025/09/30年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Srigee DLM Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 15Srigee DLM Limited to Report Second Half, 2026 Results on May 27, 2026Srigee DLM Limited announced that they will report second half, 2026 results on May 27, 2026
Reported Earnings • Nov 16First half 2026 earnings released: EPS: ₹2.25 (vs ₹5.61 in 1H 2025)First half 2026 results: EPS: ₹2.25 (down from ₹5.61 in 1H 2025). Revenue: ₹214.2m (down 39% from 1H 2025). Net income: ₹13.4m (down 44% from 1H 2025). Profit margin: 6.3% (down from 6.8% in 1H 2025). The decrease in margin was driven by lower revenue.
お知らせ • Oct 31Srigee DLM Limited to Report Q2, 2026 Results on Nov 12, 2025Srigee DLM Limited announced that they will report Q2, 2026 results on Nov 12, 2025
Reported Earnings • Sep 10Full year 2025 earnings released: EPS: ₹11.76 (vs ₹7.09 in FY 2024)Full year 2025 results: EPS: ₹11.76 (up from ₹7.09 in FY 2024). Revenue: ₹712.3m (up 31% from FY 2024). Net income: ₹50.1m (up 72% from FY 2024). Profit margin: 7.0% (up from 5.4% in FY 2024). The increase in margin was driven by higher revenue.
Reported Earnings • Jun 03Full year 2025 earnings released: EPS: ₹11.76 (vs ₹7.53 in FY 2024)Full year 2025 results: EPS: ₹11.76 (up from ₹7.53 in FY 2024). Revenue: ₹713.7m (up 31% from FY 2024). Net income: ₹50.1m (up 62% from FY 2024). Profit margin: 7.0% (up from 5.7% in FY 2024). The increase in margin was driven by higher revenue.
お知らせ • May 26Srigee DLM Limited to Report Second Half, 2025 Results on May 31, 2025Srigee DLM Limited announced that they will report second half, 2025 results on May 31, 2025
お知らせ • May 15Srigee DLM Limited to Report Second Half, 2026 Results on May 27, 2026Srigee DLM Limited announced that they will report second half, 2026 results on May 27, 2026
Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹64.00, the stock trades at a trailing P/E ratio of 9.5x. Average trailing P/E is 20x in the Chemicals industry in India.
New Risk • Nov 27New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$10m (₹710.6m market cap, or US$7.95m).
Valuation Update With 7 Day Price Move • Nov 21Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹87.45, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 25x in the Chemicals industry in India.
Reported Earnings • Nov 16First half 2026 earnings released: EPS: ₹2.25 (vs ₹5.61 in 1H 2025)First half 2026 results: EPS: ₹2.25 (down from ₹5.61 in 1H 2025). Revenue: ₹214.2m (down 39% from 1H 2025). Net income: ₹13.4m (down 44% from 1H 2025). Profit margin: 6.3% (down from 6.8% in 1H 2025). The decrease in margin was driven by lower revenue.
お知らせ • Oct 31Srigee DLM Limited to Report Q2, 2026 Results on Nov 12, 2025Srigee DLM Limited announced that they will report Q2, 2026 results on Nov 12, 2025
お知らせ • Sep 30Srigee Dlm Limited Appoints Indu Shekhar Tripathi as Non-Executive Independent DirectorSrigee DLM Limited in the 20th annual general meeting held on September 30, 2025 announced the appointment of Mr. Indu Shekhar Tripathi (DIN: 00654167) as y of the company.
New Risk • Sep 26New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹861.1m (US$9.71m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.2% average weekly change). High level of non-cash earnings (38% accrual ratio). Market cap is less than US$10m (₹861.1m market cap, or US$9.71m).
Reported Earnings • Sep 10Full year 2025 earnings released: EPS: ₹11.76 (vs ₹7.09 in FY 2024)Full year 2025 results: EPS: ₹11.76 (up from ₹7.09 in FY 2024). Revenue: ₹712.3m (up 31% from FY 2024). Net income: ₹50.1m (up 72% from FY 2024). Profit margin: 7.0% (up from 5.4% in FY 2024). The increase in margin was driven by higher revenue.
お知らせ • Sep 08Srigee DLM Limited, Annual General Meeting, Sep 30, 2025Srigee DLM Limited, Annual General Meeting, Sep 30, 2025, at 10:00 Indian Standard Time. Location: plot 39 and 40 udyog vihar, extension, ecotech ii, greater, noida, uttar pradesh, india, 201306, greater noida India
Valuation Update With 7 Day Price Move • Sep 08Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹170, the stock trades at a trailing P/E ratio of 20.3x. Average trailing P/E is 26x in the Chemicals industry in India.
Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹317, the stock trades at a trailing P/E ratio of 37.8x. Average trailing P/E is 29x in the Chemicals industry in India.
Valuation Update With 7 Day Price Move • Jun 09Investor sentiment improves as stock rises 33%After last week's 33% share price gain to ₹319, the stock trades at a trailing P/E ratio of 38.1x. Average trailing P/E is 28x in the Chemicals industry in India.
New Risk • Jun 03New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 36% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (36% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.44b market cap, or US$16.8m).
Reported Earnings • Jun 03Full year 2025 earnings released: EPS: ₹11.76 (vs ₹7.53 in FY 2024)Full year 2025 results: EPS: ₹11.76 (up from ₹7.53 in FY 2024). Revenue: ₹713.7m (up 31% from FY 2024). Net income: ₹50.1m (up 62% from FY 2024). Profit margin: 7.0% (up from 5.7% in FY 2024). The increase in margin was driven by higher revenue.
お知らせ • May 26Srigee DLM Limited to Report Second Half, 2025 Results on May 31, 2025Srigee DLM Limited announced that they will report second half, 2025 results on May 31, 2025
Board Change • May 12Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Indu Tripathi was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.